Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial.

@article{AubertinLeheudre2008IsoflavonesAC,
  title={Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial.},
  author={Myl{\`e}ne Aubertin-Leheudre and Christine Lord and Abdelouahed Khalil and Isabelle J Dionne},
  journal={Journal of women's health},
  year={2008},
  volume={17 8},
  pages={1363-9}
}
AIMS To investigate whether 6 months of isoflavone supplementation, which has been shown to be sufficient to improve menopausal symptoms, could also improve clinical cardiovascular disease (CVD) risk factors in obese postmenopausal women, compared with a placebo. METHODS A randomized double-blind placebo-controlled trial in which 50 obese postmenopausal women were divided into two groups (isoflavones vs. placebo) to examine the effect of 6 months of isoflavone supplement (70 mg) on clinical… CONTINUE READING